L. Caregaro et al., NUTRITIONAL AND PROGNOSTIC-SIGNIFICANCE OF SERUM HYPOTHYROXINEMIA IN HOSPITALIZED-PATIENTS WITH LIVER-CIRRHOSIS, Journal of hepatology, 28(1), 1998, pp. 115-121
Background/Aims: A variety of severe illnesses can induce changes in t
hyroid hormone metabolism, leading to findings referred to as ''sick e
uthyroid syndrome''. In several groups of patients the reduction of se
rum thyroxine concentration (T-4), characteristic of the low-T-4 varia
nt of sick euthyroid syndrome, has been found to be a good predictor o
f survival. Although the pathophysiology of hormonal alterations has n
ot yet been defined, nutritional deficits have been suggested to play
a role. The study aimed to define the prognostic and nutritional signi
ficance of serum thyroxine in liver cirrhosis. Methods: Thyroid hormon
es and nutritional status were evaluated in a group of 75 consecutive
hospitalized patients with cirrhosis, followed-up clinically for 12 mo
nths. Results: A low-T-4 variant of sick euthyroid syndrome was found
in 23 of the 75 enrolled patients with cirrhosis (30.6%). Serum T-4, b
ut not serum T-3, correlated with mid-arm muscle circumference (p<0.01
), an indicator of muscle protein compartment. While both serum T-3 an
d T-4 correlated directly with serum proteins and inversely with Child
-Pugh score, only T-4 was predictive of outcome. Patients with the low
-T-4 variant of sick euthyroid syndrome showed significantly lower sho
rt-and long-term survival rates compared to those with normal serum T-
4 concentrations (p<0.008 at 3 months, p<0.001 at 6 months and 1 year)
. A multivariate analysis using the proportional hazards Cox's regress
ion procedure showed that serum T-4, but not serum T-3 or nutritional
parameters, improves the prognostic capacity of Child-Pugh score (p<0.
01). Conclusions: These data indicate that the low T-4-variant of sick
euthyroid syndrome distinguishes a subgroup of patients with cirrhosi
s at risk for decreased survival. The inclusion of T-4 in the Child-Pu
gh score, by improving its prognostic power, may optimize the selectio
n of patients with advanced cirrhosis to receive specific therapy such
as transplantation.